Search for: "Watson v. Industrial Commission" Results 1 - 20 of 69
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Jun 2007, 3:13 am
[JURIST] The US Supreme Court [official website; JURIST news archive] handed down decisions in five cases Monday, including Watson v. [read post]
12 Jan 2016, 6:41 am by Michael Geist
The post The Battle Over the Future of Broadband in Canada: Mayors Tory & Watson v. [read post]
12 Mar 2013, 6:40 am by Dennis Crouch
Cardozo School of Law) On March 25, 2013, the Supreme Court will hear oral arguments in Federal Trade Commission v. [read post]
25 Apr 2007, 6:24 am
This morning, the Court will hear oral argument in Watson v. [read post]
11 Jun 2007, 4:26 pm
Watson clearly signals that private actors in heavily regulated industries such as drug companies, medical equipment makers and nuclear power plants cannot rely solely on their status as regulated entities to assert a right to removal. [read post]
14 Nov 2016, 9:16 am by Dennis Crouch
Watson Laboratories, Inc., No. 16-493 (pre-AIA, do secret sales count as prior art?) [read post]
21 Apr 2021, 4:39 pm by Kevin LaCroix
A version of this article previously appeared on the Willis Towers Watson website (here). [read post]
13 Apr 2011, 5:43 pm by INFORRM
Lord knows, even the Press Complaints Commission may decide they need a ticking-off. [read post]
7 Jan 2015, 4:01 pm by INFORRM
  A legal challenge to S.1 of DRIPA by MPs David Davis and Tom Watson is under way. [read post]
13 Mar 2013, 1:55 pm by Brett Frischmann
Crossposted from On March 25, 2013, the Supreme Court will hear oral arguments in Federal Trade Commission v. [read post]
16 Jan 2009, 5:00 am
: BMS v Hetero (GenericsWeb) India: Adding innovation to Ayurveda! [read post]
13 Jun 2007, 12:41 pm
  Such a decision was the Eighth Circuit's ruling in Watson v. [read post]
9 Apr 2009, 7:52 am
(IP Think Tank) Brazilian public-private partnerships in the pharma industry (IP tango) EU: ECJ to rule on reference on SPC Regulation interpretation from Lithuania in Kirin Amgen, Inc. v Lietuvos Respublikos valstybinis patentų biuras (The SPC Blog) India: Delhi High Court Dasatinib order: Is patent-drug regulatory linkage a necessity? [read post]